314 related articles for article (PubMed ID: 12067438)
61. Bimodal regulation of axonal transport by the GDNF-RET signalling axis in healthy and diseased motor neurons.
Rhymes ER; Tosolini AP; Fellows AD; Mahy W; McDonald NQ; Schiavo G
Cell Death Dis; 2022 Jul; 13(7):584. PubMed ID: 35798698
[TBL] [Abstract][Full Text] [Related]
62. Emerging mechanisms of molecular pathology in ALS.
Peters OM; Ghasemi M; Brown RH
J Clin Invest; 2015 May; 125(5):1767-79. PubMed ID: 25932674
[TBL] [Abstract][Full Text] [Related]
63. Gene Therapy for ALS: progress and prospects.
Azzouz M
Biochim Biophys Acta; 2006; 1762(11-12):1122-7. PubMed ID: 16806843
[TBL] [Abstract][Full Text] [Related]
64. Impaired retrograde axonal transport of adenovirus-mediated E. coli LacZ gene in the mice carrying mutant SOD1 gene.
Murakami T; Nagano I; Hayashi T; Manabe Y; Shoji M; Setoguchi Y; Abe K
Neurosci Lett; 2001 Aug; 308(3):149-52. PubMed ID: 11479010
[TBL] [Abstract][Full Text] [Related]
65. Additivity and potentiation of IGF-I and GDNF in the complete rescue of postnatal motor neurons.
Bilak MM; Corse AM; Kuncl RW
Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Jun; 2(2):83-91. PubMed ID: 11675876
[TBL] [Abstract][Full Text] [Related]
66. [Effect and mechanism of marrow stromal cells within cerebrospinal fluid on SOD1 transgenic mice].
Zhou C; Zhang C; Yao QQ; Zhao CP; Zhang C
Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(29):2324-8. PubMed ID: 24300157
[TBL] [Abstract][Full Text] [Related]
67. Nerve injection of viral vectors efficiently transfers transgenes into motor neurons and delivers RNAi therapy against ALS.
Wu R; Wang H; Xia X; Zhou H; Liu C; Castro M; Xu Z
Antioxid Redox Signal; 2009 Jul; 11(7):1523-34. PubMed ID: 19344276
[TBL] [Abstract][Full Text] [Related]
68. Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis.
Miller TM; Kaspar BK; Kops GJ; Yamanaka K; Christian LJ; Gage FH; Cleveland DW
Ann Neurol; 2005 May; 57(5):773-6. PubMed ID: 15852369
[TBL] [Abstract][Full Text] [Related]
69. Current developments in gene therapy for amyotrophic lateral sclerosis.
Scarrott JM; Herranz-Martín S; Alrafiah AR; Shaw PJ; Azzouz M
Expert Opin Biol Ther; 2015 Jul; 15(7):935-47. PubMed ID: 25959569
[TBL] [Abstract][Full Text] [Related]
70. Analysis of neurotrophic factors in limb and extraocular muscles of mouse model of amyotrophic lateral sclerosis.
Harandi VM; Lindquist S; Kolan SS; Brännström T; Liu JX
PLoS One; 2014; 9(10):e109833. PubMed ID: 25334047
[TBL] [Abstract][Full Text] [Related]
71. Transplantation of Neural Progenitor Cells Expressing Glial Cell Line-Derived Neurotrophic Factor into the Motor Cortex as a Strategy to Treat Amyotrophic Lateral Sclerosis.
Thomsen GM; Avalos P; Ma AA; Alkaslasi M; Cho N; Wyss L; Vit JP; Godoy M; Suezaki P; Shelest O; Bankiewicz KS; Svendsen CN
Stem Cells; 2018 Jul; 36(7):1122-1131. PubMed ID: 29656478
[TBL] [Abstract][Full Text] [Related]
72. Intramuscular transplantation of bone marrow cells prolongs the lifespan of SOD1
Rando A; Pastor D; Viso-León MC; Martínez A; Manzano R; Navarro X; Osta R; Martínez S
Stem Cell Res Ther; 2018 Apr; 9(1):90. PubMed ID: 29625589
[TBL] [Abstract][Full Text] [Related]
73. Hypoxic induction of vascular endothelial growth factor is selectively impaired in mice carrying the mutant SOD1 gene.
Murakami T; Ilieva H; Shiote M; Nagata T; Nagano I; Shoji M; Abe K
Brain Res; 2003 Nov; 989(2):231-7. PubMed ID: 14556945
[TBL] [Abstract][Full Text] [Related]
74. Recombinant adeno-associated virus-mediated global anterograde delivery of glial cell line-derived neurotrophic factor to the spinal cord: comparison of rubrospinal and corticospinal tracts in the rat.
Foust KD; Flotte TR; Reier PJ; Mandel RJ
Hum Gene Ther; 2008 Jan; 19(1):71-82. PubMed ID: 18072858
[TBL] [Abstract][Full Text] [Related]
75. Overexpression of the Cdk5 inhibitory peptide in motor neurons rescue of amyotrophic lateral sclerosis phenotype in a mouse model.
Bk B; Skuntz S; Prochazkova M; Kesavapany S; Amin ND; Shukla V; Grant P; Kulkarni AB; Pant HC
Hum Mol Genet; 2019 Oct; 28(19):3175-3187. PubMed ID: 31189016
[TBL] [Abstract][Full Text] [Related]
76. Motoneurons crave glial cell line-derived neurotrophic factor.
Bohn MC
Exp Neurol; 2004 Dec; 190(2):263-75. PubMed ID: 15530868
[TBL] [Abstract][Full Text] [Related]
77. Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis.
Nichols NL; Gowing G; Satriotomo I; Nashold LJ; Dale EA; Suzuki M; Avalos P; Mulcrone PL; McHugh J; Svendsen CN; Mitchell GS
Am J Respir Crit Care Med; 2013 Mar; 187(5):535-42. PubMed ID: 23220913
[TBL] [Abstract][Full Text] [Related]
78. [Regenerative therapies for amyotrophic lateral sclerosis using hepatocyte growth factor].
Aoki M; Warita H; Suzuki N; Kato M; Itoyama Y
Rinsho Shinkeigaku; 2011 Nov; 51(11):1195-8. PubMed ID: 22277532
[TBL] [Abstract][Full Text] [Related]
79. A commentary on glial cell line-derived neurotrophic factor (GDNF). From a glial secreted molecule to gene therapy.
Bohn MC
Biochem Pharmacol; 1999 Jan; 57(2):135-42. PubMed ID: 9890561
[TBL] [Abstract][Full Text] [Related]
80. Antisense peptide nucleic acid-mediated knockdown of the p75 neurotrophin receptor delays motor neuron disease in mutant SOD1 transgenic mice.
Turner BJ; Cheah IK; Macfarlane KJ; Lopes EC; Petratos S; Langford SJ; Cheema SS
J Neurochem; 2003 Nov; 87(3):752-63. PubMed ID: 14535957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
